Vector Control, Sauver des Vies

Our partners

Since our formation in 2005 IVCC has worked with partners from the public and private sector. We work with experts in industry and academia, and with committed funders and other ngos and non-profit organisations. We also work with field trial site centres in sub-Saharan Africa. In addition to working with organisations, we work with individual experts, who make a major contribution to our Expert Scientific Advisory Committees (ESACs) and who take part in our Governance.

What people say about us

  • Product development partners like IVCC have resulted in accelerating new technology development and we’re seeing more promising products in the pipeline than we ever have before for. For an investor that’s an exciting deliverable and expectation.
    Admiral Tim Ziemer, PMI
  • The United States government is committed to the partnership with IVCC, as a product development partnership, because it’s all about Vector Control products—to preserve the effect of products that we have today, but, more importantly, to look for and accelerate the development and delivery of new projects for our tool kit to sustain and move the world towards a malaria-free vision.
    Admiral Tim Ziemer, PMI
  • There are challenges that we could not have easily overcome without IVCC. At the beginning of when we started working we were struggling to develop some of the products. Now we have products that we scientists could not have achieved without interacting directly with companies to achieve one goal. We look forward to collaborating with IVCC and to deliver on their promise.
    Raphael N'Guessen, Medical Entomologist, Benin
  • The partnership with IVCC is vitally important to LITE. When a new project comes to IVCC we talk about the type of testing that’s needed and the type of mosquitoes that we need in the test. Then a schedule of work is turned into a protocol and the testing is scheduled into our programme.
    Helen Williams, LITE Manager
  • The co-operation with IVCC enables us to develop projects for public health which we would not normally be able to do. And IVCC, especially the ESAC, are important sparring partners. If we face a problem we can discuss it together.
    Egon Weinmueller, BASF
  • I have found IVCC very flexible in giving advice to help us and guide our science towards needs and applications. We do basic research, basic science in molecular work, and IVCC guides us on how to transform the information that we get from molecular biology to useful applicable products.
    John Vontas, University of Crete
  • Of the public-private partnerships I’ve worked with, I would say that IVCC is probably the best in terms of its focus and its mission and its desire to deliver. I’m very impressed with the level of enthusiasm, commitment and technical expertise, within the group. One of the things that I really was very surprised about was the speed at which we’ve managed to do things.
    John Lucas, Sumitomo Chemical
  • Working with IVCC at our field trial sites is helping us, as effective scientists, on two levels. First, it’s helping build the capacity to work on insecticide resistance and manage our screening problems so we can use the data to guide the national malaria control problem. Secondly, which is extremely important, it’s about looking at new products that will really help to solve the problem of insecticide resistance.
    Aboulaye Diabaté, IRSS, Burkina Faso
  • IVCC is putting scientists on track, not only to publish research, but actually to put the research in a direction that the community can benefit from in the form of products. As a scientist in the academic world you are evaluated for papers and not so much for real economic or beneficial outcomes for the communities.
    Gunter Muller, Hebrew University
  • In the last ten years we’ve made remarkable progress, primarily because of effective strategies and implementation of Vector Control products, like insecticide treated bed nets and indoor residual spraying. However, we’re sobered by the reality that, if we let up or if we don’t manage and respond to the resistance being developed by the mosquito and parasite our current products will be less effective.
    Admiral Tim Ziemer, President's Malaria Initiative